Developing the Barts Health strategy Presentation to Waltham Forest - - PowerPoint PPT Presentation
Developing the Barts Health strategy Presentation to Waltham Forest - - PowerPoint PPT Presentation
Developing the Barts Health strategy Presentation to Waltham Forest Health, Adults and Older Persons Scrutiny Sub-committee 13 March 2013 Purpose To provide members with an overview of the emerging Barts Health strategy To outline
Purpose
- To provide members with an overview of the
emerging Barts Health strategy
- To outline how our partners can inform our
planning
- To briefly outline our role as a founding partner
- f UCLPartners
- To update members on performance at Whipps
Cross Hospital
Barts Health – Changing Lives
Changing lives - our vision
Our ambition is for east London to have health services in which we can all take pride. These services will reach beyond our hospitals and provide care where it is needed most – at home, in our communities, or in specialist facilities across the boroughs. Outstanding research, a commitment to learning and improvement, and a focus on partnership, will allow Barts Health to succeed. Success will see the health of the population transformed and inequalities in health reduced substantially. This commitment is what defines our organisation and
- ur values.
Why have a strategy?
- Our strategy drives our business plan and enables us to deliver on
- ur Trust objectives
- A strategy ensures that we are all working together to deliver an
agreed direction of travel and enables us to respond to business development opportunities as they become evident (e.g. hyper- acute stroke unit designation)
- By having a strategy that we are all signed up to we will ensure
that we provide the right services for local people, reflecting changes in our population, technology and commissioner intentions
- Our strategy will ensure that we attain Foundation Trust status in
line with Government guidance and realise the benefits of our recent merger
How we will deliver a Barts Health Strategy
- It is acknowledged that a Trust wide strategy needs to be
embedded in our operational model. It has been agreed that all service lines will need to engage in the strategy process
- ver the next 12 months
- To enable this, numerous conversations have taken place
with clinical leaders and will continue over the coming months
- All service lines are being asked to commit to brand
standards of excellence: all services have an opportunity to be involved in their development through clinical and Clinical Academic Group leaders
- A first formal draft was shared with the Board in February
2013
Working Draft - Last Modified 12/10/2012 21:12:46 Printed 07/09/2012 13:55:16
- -- COMMERCIAL IN CONFIDENCE ----
DRAFT FOR DISCUSSION ONLY 6
Trust strategy – the key components
Strategic initiatives Changing lives An academically based health system delivering excellent clinical outcomes and health improvement Strategic enablers
- a. Board and quality governance
- b. Clinical Leadership
- c. Informatics and Systems
- d. HR, OD & Workforce
2 1 Brand standards: Consistently excellent quality and delivery Clinical and financial sustainability, enabled by SLR (achieved via basic cost management & CIPs, commercial and partnership opportunities, service redesign) Foundations to become a successful FT Selected clini- cal distinctive- ness Integrated care Population health Teaching and training excellence Research excellence 4 5 6 7 3
- Caring and Compassionate
- Listening and understanding
- Working together to achieve
ambitious results
- Improving and Innovating
- Valuing every member of staff
Values
- e. Performance management
- f. Estates optimisation
Working Draft - Last Modified 12/10/2012 21:12:46 Printed 07/09/2012 13:55:16
- -- COMMERCIAL IN CONFIDENCE ----
DRAFT FOR DISCUSSION ONLY 7
1-slide introduction to selected distinctiveness: Barts Health could think about its portfolio of services as falling into three broad categories
Brand standard performers World leading Deep local impact, nationally acclaimed, world class
- Quality, Safety and Patient Experience
- Delivery and Operational efficiency,
including finances
- Basic research and teaching
- Staff and patient engagement
All services need to meet brand standards on
- Are critical to addressing
local population needs
- Have significant
- pportunity to develop a
nationally distinctive profile within Barts Health, through partnerships
- Have healthy current
and future scale and margins A subset of services which excel on all the brand standards and also
- Reputation and Recognition
- Research power
- Excellence in Teaching and
Training
- World class infrastructure and
investment levels One or two globally acknowledged truly distinctive service lines, that bring international renown and acclaim for Barts Health along the dimensions of
Emerging priorities
The emerging early contributors to our strategy are:
- Cancer
- Cardiovascular
- Care of the elderly
- Child health
- Diabetes
- Maternity
- Stroke
- Trauma
We will also consider two “cross cutting” themes that will cover the Trust – integrated care and public/population health building on the work underway between the Trust and our local authority and primary care partners.
Working with our partners
- It is important that in developing our strategy we work with
- ur local partners including: local authorities, patients and
the public, Queen Mary, University of London and our commissioners
- If, as a result of our strategy development, we propose to
change the way our services are provided we may need to formally consult with local people and partners
- Barts Health must also consider the NHS Co-operation and
Competition Panel recommendations with regards to any changes proposed for Newham Hospital
We will shortly be writing to interested parties with the draft strategy asking for views and comments
UCLPartners
UCLPartners is one of five accredited academic health science systems in the UK. Its purpose is to translate cutting edge research and innovation into measurable health gain for patients and populations – in London, across the UK, and globally. Solutions are:
- Patient-led, organising care around patients’ needs and
preferences
- Population-focused, taking a system-wide view to drive improved
health outcomes at speed and scale
- Cross-boundary, spanning primary, secondary and tertiary care,
and connecting different phases of academic research It is important that Barts Health has a strategy in order to respond to and participate in the UCLPartners debate.
UCLP: Integrated Cardiovascular System
- An Integrated Cardiovascular System (ICVS) has been established
as part of UCLP
- On 20 February, Clinicians from across Barts Health, UCLH and
UCLP announced an intention to engage/consult on moving the Heart Hospital, operated by UCLH, to St Bartholomew’s Hospital in the City of London. This would create a world-class centre of excellence for cardiovascular services, combining the very best of talent from the Heart Hospital and the London Chest Hospital – which will move to St Bartholomew’s following the completion of the new hospital in 2014.
- This agreement in principle, put patients at the very heart of local
health services with the hospitals trust putting aside their
- rganisational aspirations to do what is right for patients across a
large geographical area.
UCLP: Integrated Cancer System
- An Integrated Cancer System (ICS) has been established under the
name of London Cancer.
- Clinicians from across central and east London have been working
together to look at 14 different cancer tumour groups: specialist bladder and prostate; specialist renal; specialist head and neck; Oesophago- gastric; brain; gynaecological; hepato-pancreatic biliary; colorectal; HPC transplant; breast; lung; teenage/young people and radiotherapy.
- Our commissioners are engaging on bladder and prostate and
specialist renal cancer centralisation to single units at present. It is proposed that the units would be at University College London Hospitals NHS Foundation Trust (UCLH) and Royal Free London NHS Foundation Trust respectively. Views are sought by 29 March to cancer@elc.nhs.uk
- The other tumour groups will be making recommendations in the next